J Physiol Wellcome Trust-funded researchers
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Physiology in Press

First published online on April 25, 2008.
Copyright © 2008 by The Physiological Society
This Article
Right arrow Full Text (Rapid PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
586/12/2975    most recent
jphysiol.2008.153163v2
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Takakura, A. C
Right arrow Articles by Guyenet, P. G.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takakura, A. C
Right arrow Articles by Guyenet, P. G.

Received February 27, 2008
Revised March 25, 2008
Accepted after revision April 17, 2008

Selective lesion of retrotrapezoid Phox2b-expressing neurons raises the apneic threshold in rats

Ana C Takakura1, Thiago S Moreira1, Ruth L Stornetta2, Gavin H West2, Justin M Gwilt2, and Patrice G. Guyenet3*

1 UNIFESP-EPM, Sao Paulo
2 University of Virginia
3 University of Virginia Health System

* To whom correspondence should be addressed. E-mail: pgg{at}virginia.edu.

Injection of the neurotoxin saporin-substance P (SSP-SAP) into the retrotrapezoid nucleus (RTN) attenuates the central chemoreflex in rats. Here we ask whether these deficits are caused by the destruction of a specific type of interneuron that expresses the transcription factor Phox2b and is non-catecholaminergic (Phox2b+TH-). We show that RTN contains around 2100 Phox2b+TH- cells. Injections of SSP-SAP into RTN destroyed Phox2b+TH- neurons but spared facial motoneurons, catecholaminergic and serotonergic neurons and the ventral respiratory column caudal to the facial motor nucleus. Two weeks after SSP-SAP, the apneic threshold measured under anesthesia was unchanged when fewer than 57% of the Phox2b+TH- neurons were destroyed. However, destruction of 70 ± 3.5 % of these cells was associated with a dramatic rise of the apneic threshold (from 5.6 to 7.9% end-expiratory PCO2). In anesthetized rats with unilateral lesions of around 70% of the Phox2b+TH- neurons, acute inhibition of the contralateral intact RTN with muscimol instantly eliminated phrenic nerve discharge (PND) but normal PND could usually be elicited by strong peripheral chemoreceptor stimulation (8/12 rats). Muscimol had no effect in rats with an intact contralateral RTN. In conclusion, the destruction of the Phox2b+TH- neurons is a plausible cause of the respiratory deficits caused by injection of SSP-SAP into RTN. Two weeks after toxin injection, 70% of these cells must be killed to cause a severe attenuation of the central chemoreflex under anesthesia. The loss of an even greater percentage of these cells would presumably be required to produce significant breathing deficits in the awake state.


Key words: Central nervous system • Chemoreflex • Respiratory control







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 The Physiological Society.